|
Jeffrey Long-McGie is a Healthcare Analyst at Ridgeback Capital Management. Jeff�s business experience includes positions of Vice President of Business Development at Andrx Pharmaceuticals and Andrx Therapeutics. Jeff�s investment experience includes positions at ThinkEquity and A.G. Edwards where he was responsible for coverage of the generic pharmaceutical industry. His educational background includes an MBA from Saint Louis University, a Master�s in Biology from Washington University and a BS in Microbiology from California State University. Currently, Jeff serves as a member of the Finance Committee for the Food and Drug Law Institute. Additionally, Jeff has served as a Consultant for multiple pre-IPO stage Pharmaceutical Companies. | 